Follow-up after treatment is an important part of cancer care. Follow-up for acute myelogenous leukemia (AML) is often shared among the cancer specialists (oncologists or hematologists) and your family doctor. Your healthcare team will work with you to decide on follow-up care to meet your needs.
Don’t wait until your next scheduled appointment to report any new symptoms and symptoms that don’t go away. Tell your healthcare team if you have:
The chance of AML recurring is greatest during treatment or shortly after treatment is finished. It is unusual for AML to recur if no signs of AML are present within a few years of finishing treatment.
Follow-up after treatment for AML is based on your personal needs. It generally lasts for many years. People in remission need to be examined regularly. Follow-up visits are usually scheduled:
During a follow-up visit, your healthcare team will usually ask questions about the side effects of treatment and how you’re coping.
Your doctor may do a physical exam, which can include:
Tests are often part of follow-up care. You may have:
If a recurrence is found, your healthcare team will assess you to determine the best treatment options.
Find out more about these tests and procedures.
To make the decisions that are right for you, ask your healthcare team questions about follow-up.